Contact Us - Elmira Daily

Elmira Daily

101 E Church St,
Elmira,
New York 14901, USA
Phone: +1 607-893-8712
Email: [email protected]

For More Information :

To write us, fill the following contact form :

Mental Health

Avoid Phones to Take Breaks Throughout Day

By Robert Sikorski on August 20, 2019 5:52 AM EDT

Using a phone to take a break throughout mentally challenging tasks doesn't permit the brain to recharge effectively and may end in a more mediocre...

Scientist Found the Mechanism Behind Chronic Stress Causing Brain Damage

By Robert Sikorski on August 12, 2019 5:52 AM EDT

DGIST published on July 2 that Professor Seong-Woon Yu's team in the Department of Brain and Cognitive Sciences found that chronic stress causes the autophagic...

Colorectal Cancer in Young People Are On Raise in Canada

By Robert Sikorski on August 1, 2019 8:29 AM EDT

Even with all of the progressions in medical science, the world has seen in the last few years, and there are still significant issues affecting...

A Specific Psychotherapeutic Approach in Chronic Depression Might Get Efectless After Two Years

By Robert Sikorski on July 29, 2019 12:57 PM EDT

A study published in the latest issue of Psychotherapy and Psychosomatics indicates that the benefits of a specific psychotherapeutic approach may disappear after two years from the...

Studies Show People Committed to Science Can Promote Belief in God

By Robert Sikorski on July 22, 2019 8:09 AM EDT

Most Americans imagine science and religion are incompatible. However, current research suggests that scientific commitment can promote belief in God. Researchers from the Arizona State...

Pharma

Astrazeneca Announced Positive Results from The Landmark Part III DAPA-HF Trial

By Nicholas Shorts on August 21, 2019 9:29 AM EDT

AstraZeneca announced positive results from the landmark Part III DAPA-HF trial which confirmed that Farxiga (dapagliflozin) met the primary composite endpoint with a statistically-important and...

FDA Approved Pretomanid Tablets in Combination with Bedaquiline and Linezolid for TB

By Nicholas Shorts on August 17, 2019 12:01 PM EDT

The US Food and Drug Administration authorized Pretomanid Tablets in combination with bedaquiline and linezolid for the remedy of a particular sort of highly treatment-resistant...

Bayer AG Buys BlueRock Therapeutics to Modify Cell Therapy

By Nicholas Shorts on August 9, 2019 11:45 AM EDT

Bayer AG and BlueRock Therapeutics declared an agreement under which Bayer will acquire BlueRock Therapeutics, a privately held US-headquartered biotechnology company targeted on developing engineered...

FDA Approved Turalio Capsules for Treatment of Tenosynovial Giant Cell Tumor

By Nicholas Shorts on August 7, 2019 8:32 AM EDT

The Food and Drug Administration approved Turalio (pexidartinib) capsules for the treatment of adult sufferers with symptomatic tenosynovial giant cell tumor (TGCT) related to severe...

Price Tag for A Life Costs – $2.1 Million Price Tag for A Life Costs - $2.1 Million

Price Tag for A Life Costs – $2.1 Million

By Nicholas Shorts on August 1, 2019 7:30 AM EDT

When the Food and Drug Administration (FDA) accepted Zolgensma, a lifesaving medication to treat spinal muscular atrophy, parents of younger kids with the rare and deadly...